The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
Rare Diseases (RD) are defined by their prevalence in less than 5 in 10,000 of the general population. Considered individually, each RD may seem insignificant, but together they add up to more than 7000 different diseases. Research in RD is not attractive for pharmaceutical companies since it is unl...
Main Authors: | Angel M. Cuesta, Eunate Gallardo-Vara, Juan Casado-Vela, Lucía Recio-Poveda, Luisa-María Botella, Virginia Albiñana |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/8/4217 |
Similar Items
-
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
by: Virginia Albiñana, et al.
Published: (2022-08-01) -
Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease
by: Virginia Albiñana, et al.
Published: (2020-08-01) -
Propranolol Modulates Cerebellar Circuit Activity and Reduces Tremor
by: Joy Zhou, et al.
Published: (2022-12-01) -
Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma
by: Virginia Albiñana, et al.
Published: (2022-01-01) -
Refractive Outcome in Preterm Newborns With ROP After Propranolol Treatment. A Retrospective Observational Cohort Study
by: Luca Filippi, et al.
Published: (2019-11-01)